{"id":408576,"date":"2021-01-05T09:03:24","date_gmt":"2021-01-05T14:03:24","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=408576"},"modified":"2021-01-05T09:03:24","modified_gmt":"2021-01-05T14:03:24","slug":"revel-novuhealth-become-icario","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/","title":{"rendered":"Revel + NovuHealth Become Icario"},"content":{"rendered":"

\nNation’s leading health action company reveals new brand reflecting the company\u2019s mission to connect people to health
\n<\/h2>\n
\n

MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) — Revel + NovuHealth today announced the launch of its new name and brand, Icario\u2122<\/sup> (\u201cih-car-ee-oh\u201d). The new brand represents the combined business of two market leaders that merged in October 2020. Icario creates value by uniting pioneering technology, data science and behavioral insights to make the world a healthier place, one person at a time. Icario\u2019s technology and services currently support more than 50 leading healthcare payers, including seven of the ten largest health plans in the United States.<\/p>\n

\u201cWe chose the Icario name and brand to represent a successful, growing business that deeply understands people and is focused on making healthcare more human through personalized communication,\u201d said Steve Wigginton, CEO of Icario. \u201cBringing Revel and NovuHealth together under one brand has allowed us to accelerate new product development to solve healthcare problems quickly in a highly interconnected way. There has never been a more important time to improve people\u2019s health, and the Icario team is driven to achieve the highest health outcomes on behalf of our customers through an ever-expanding suite of capabilities.\u201d<\/p>\n

Icario currently helps more than 10 million health plan members per month take health actions that drive better outcomes. Icario\u2019s expanded data analytics, adaptive multi-channel platform, and behavioral insights allow health plan customers to connect with their members in a highly personalized way. Icario\u2019s deep expertise in Medicare and Medicaid \u2014 supporting critical quality, satisfaction and outcome measures that drive plan performance \u2014 enables the company to partner with innovative health plans and risk-bearing entities to accelerate innovation and growth.<\/p>\n

Check out the new Icario website and brand design here: www.icariohealth.com<\/u><\/a>.<\/p>\n

\n About Icario<\/strong>
\n
Icario is the leading health action company focused on connecting people to health. Icario uses pioneering behavioral research, data science and our adaptive multi-channel platform to deliver personalization at scale for the most trusted healthcare organizations in all 50 states, including seven of the 10 largest health plans. Learn more at www.icariohealth.com<\/u><\/a>.<\/p>\n

\n
\n Media Contact:<\/u>
\n <\/strong>
\n
Sandi Scott
sscott@tunheim.com<\/a>\u00a0
(651) 208-4582<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Nation’s leading health action company reveals new brand reflecting the company\u2019s mission to connect people to health MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) — Revel + NovuHealth today announced the launch of its new name and brand, Icario\u2122 (\u201cih-car-ee-oh\u201d). The new brand represents the combined business of two market leaders that merged in October 2020. Icario creates value by uniting pioneering technology, data science and behavioral insights to make the world a healthier place, one person at a time. Icario\u2019s technology and services currently support more than 50 leading healthcare payers, including seven of the ten largest health plans in the United States. \u201cWe chose the Icario name and brand to represent a successful, growing business that deeply understands people … <\/p>\n

Continue reading “Revel + NovuHealth Become Icario”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-408576","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nRevel + NovuHealth Become Icario - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revel + NovuHealth Become Icario - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Nation’s leading health action company reveals new brand reflecting the company\u2019s mission to connect people to health MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) — Revel + NovuHealth today announced the launch of its new name and brand, Icario\u2122 (\u201cih-car-ee-oh\u201d). The new brand represents the combined business of two market leaders that merged in October 2020. Icario creates value by uniting pioneering technology, data science and behavioral insights to make the world a healthier place, one person at a time. Icario\u2019s technology and services currently support more than 50 leading healthcare payers, including seven of the ten largest health plans in the United States. \u201cWe chose the Icario name and brand to represent a successful, growing business that deeply understands people … Continue reading "Revel + NovuHealth Become Icario"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-05T14:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDI3NCMzOTAzNjI0IzUwMDA3NTUxMg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revel-novuhealth-become-icario\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revel-novuhealth-become-icario\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Revel + NovuHealth Become Icario\",\"datePublished\":\"2021-01-05T14:03:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revel-novuhealth-become-icario\\\/\"},\"wordCount\":354,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revel-novuhealth-become-icario\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDI3NCMzOTAzNjI0IzUwMDA3NTUxMg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revel-novuhealth-become-icario\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revel-novuhealth-become-icario\\\/\",\"name\":\"Revel + NovuHealth Become Icario - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revel-novuhealth-become-icario\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revel-novuhealth-become-icario\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDI3NCMzOTAzNjI0IzUwMDA3NTUxMg==\",\"datePublished\":\"2021-01-05T14:03:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revel-novuhealth-become-icario\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revel-novuhealth-become-icario\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revel-novuhealth-become-icario\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDI3NCMzOTAzNjI0IzUwMDA3NTUxMg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMDI3NCMzOTAzNjI0IzUwMDA3NTUxMg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revel-novuhealth-become-icario\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revel + NovuHealth Become Icario\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Revel + NovuHealth Become Icario - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/","og_locale":"en_US","og_type":"article","og_title":"Revel + NovuHealth Become Icario - Market Newsdesk","og_description":"Nation’s leading health action company reveals new brand reflecting the company\u2019s mission to connect people to health MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) — Revel + NovuHealth today announced the launch of its new name and brand, Icario\u2122 (\u201cih-car-ee-oh\u201d). The new brand represents the combined business of two market leaders that merged in October 2020. Icario creates value by uniting pioneering technology, data science and behavioral insights to make the world a healthier place, one person at a time. Icario\u2019s technology and services currently support more than 50 leading healthcare payers, including seven of the ten largest health plans in the United States. \u201cWe chose the Icario name and brand to represent a successful, growing business that deeply understands people … Continue reading \"Revel + NovuHealth Become Icario\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-05T14:03:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDI3NCMzOTAzNjI0IzUwMDA3NTUxMg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Revel + NovuHealth Become Icario","datePublished":"2021-01-05T14:03:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/"},"wordCount":354,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDI3NCMzOTAzNjI0IzUwMDA3NTUxMg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/","name":"Revel + NovuHealth Become Icario - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDI3NCMzOTAzNjI0IzUwMDA3NTUxMg==","datePublished":"2021-01-05T14:03:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDI3NCMzOTAzNjI0IzUwMDA3NTUxMg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMDI3NCMzOTAzNjI0IzUwMDA3NTUxMg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revel-novuhealth-become-icario\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Revel + NovuHealth Become Icario"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=408576"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408576\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=408576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=408576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=408576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}